New cell therapy combo targets tough stomach cancers
Disease control
Recruiting now
This early-stage trial tests a new treatment for advanced gastric cancer that has not responded to standard therapies. It combines a special vaccine made from the patient's own tumor markers (neoantigens) with immune cells trained to attack the cancer. The main goals are to see i…
Phase: PHASE1 • Sponsor: Jia Wei • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC